JP Morgan Private Wealth Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,896
| Closed | -$211K | – | 1685 |
|
|
2023
Q1 | $211K | Sell |
5,896
-313
| -5% | -$11.8K | ﹤0.01% | 1810 |
|
|
2022
Q4 | $235K | Sell |
6,209
-461
| -7% | -$19.4K | ﹤0.01% | 1753 |
|
|
2022
Q3 | $295K | Buy |
6,670
+654
| +11% | +$27.6K | ﹤0.01% | 1653 |
|
|
2022
Q2 | $223K | Sell |
6,016
-90
| -1% | -$3.39K | ﹤0.01% | 1780 |
|
|
2022
Q1 | $226K | Buy |
+6,106
| New | +$200K | ﹤0.01% | 1866 |
|
|
2021
Q1 | – | Sell |
-5,487
| Closed | -$310K | – | 1775 |
|
|
2020
Q4 | $310K | Buy |
5,487
+439
| +9% | +$21.9K | ﹤0.01% | 1484 |
|
|
2020
Q3 | $240K | Sell |
5,048
-373
| -7% | -$20.7K | ﹤0.01% | 1454 |
|
|
2020
Q2 | $320K | Sell |
5,421
-195
| -3% | -$10.8K | ﹤0.01% | 1283 |
|
|
2020
Q1 | $266K | Sell |
5,616
-6,445
| -53% | -$359K | ﹤0.01% | 1177 |
|
|
2019
Q4 | $729K | Sell |
12,061
-5,782
| -32% | -$344K | ﹤0.01% | 908 |
|
|
2019
Q3 | $1.07M | Sell |
17,843
-4,265
| -19% | -$278K | 0.01% | 731 |
|
|
2019
Q2 | $1.42M | Sell |
22,108
-1,298
| -6% | -$91.8K | 0.01% | 663 |
|
|
2019
Q1 | $1.9M | Sell |
23,406
-1,934
| -8% | -$125K | 0.01% | 624 |
|
|
2018
Q4 | $1.37M | Sell |
25,340
-695
| -3% | -$35.4K | 0.01% | 655 |
|
|
2018
Q3 | $1.34M | Sell |
26,035
-171
| -0.7% | -$8.03K | 0.01% | 735 |
|
|
2018
Q2 | $1.09M | Buy |
26,206
+3,877
| +17% | +$172K | 0.01% | 743 |
|
|
2018
Q1 | $984K | Buy |
22,329
+935
| +4% | +$47.5K | 0.01% | 653 |
|
|
2017
Q4 | $1.08M | Sell |
21,394
-2,269
| -10% | -$124K | 0.01% | 641 |
|
|
2017
Q3 | $1.2M | Buy |
23,663
+646
| +3% | +$33.8K | 0.01% | 583 |
|
|
2017
Q2 | $1.17M | Buy |
23,017
+878
| +4% | +$40.9K | 0.01% | 577 |
|
|
2017
Q1 | $890K | Buy |
22,139
+268
| +1% | +$12K | 0.01% | 666 |
|
|
2016
Q4 | $1.05M | Buy |
21,871
+4,649
| +27% | +$184K | 0.01% | 592 |
|
|
2016
Q3 | $631K | Sell |
17,222
-397
| -2% | -$12.4K | 0.01% | 712 |
|
|
2016
Q2 | $410K | Sell |
17,619
-1,691
| -9% | -$54.5K | ﹤0.01% | 852 |
|
|
2016
Q1 | $782K | Sell |
19,310
-2,302
| -11% | -$93.5K | 0.01% | 618 |
|
|
2015
Q4 | $1.34M | Buy |
21,612
+1,482
| +7% | +$80K | 0.01% | 457 |
|
|
2015
Q3 | $814K | Sell |
20,130
-3,731
| -16% | -$193K | 0.01% | 516 |
|
|
2015
Q2 | $1.37M | Sell |
23,861
-817
| -3% | -$51.9K | 0.02% | 434 |
|
|
2015
Q1 | $1.57M | Buy |
24,678
+888
| +4% | +$60.2K | 0.02% | 421 |
|
|
2014
Q4 | $1.47M | Buy |
23,790
+5,287
| +29% | +$261K | 0.02% | 441 |
|
|
2014
Q3 | $718K | Buy |
18,503
+4,780
| +35% | +$169K | 0.01% | 603 |
|
|
2014
Q2 | $473K | Buy |
13,723
+4,278
| +45% | +$135K | 0.01% | 586 |
|
|
2014
Q1 | $408K | Buy |
+9,445
| New | +$458K | 0.01% | 635 |
|
Other funds holding IONS
BG
TBC
PAMS
JP Morgan Private Wealth Advisors's IONS Position: Q2 2023 in Review
JP Morgan Private Wealth Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2023, closing a stake of 5,896 shares — an estimated $211K sold.
JP Morgan Private Wealth Advisors first reported a position in IONS in Q1 2014 and held it in 33 quarters. The position peaked at $1.9M in Q1 2019. 305 funds tracked by Wall St. Rank hold IONS as of Q2 2023.
- JP Morgan Private Wealth Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- JP Morgan Private Wealth Advisors sold 5,896 Ionis Pharmaceuticals shares in Q2 2023, an estimated $211K.
- JP Morgan Private Wealth Advisors first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 33 quarters.
- JP Morgan Private Wealth Advisors's Ionis Pharmaceuticals position peaked at $1.9M in Q1 2019.
- 305 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.